Sabah Hadi
Child & Adolescent Psychiatry · Frederick, MDNPI 1396818803
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,356 of the $7,274 with a category attached, or 87.4%. It is spread thinly across 21 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,211 and has fallen 65.1% since, to $772 in 2025. Among child & adolescent psychiatry clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 275 payments — averaging $26.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$1K
- Lundbeck LLC$1K
- Takeda Pharmaceuticals U.S.A., Inc.$993
- Otsuka America Pharmaceutical, Inc.$782
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$687
- Supernus Pharmaceuticals, Inc.$613
- plus $2K from 15 others
What the payments were for
- Travel & lodging$85612%
- Food & beverage$6,35687%
- Education$621%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 2 | $1,368 |
| Lundbeck LLC | 49 | $1,241 |
| Takeda Pharmaceuticals U.S.A., Inc. | 52 | $993 |
| Otsuka America Pharmaceutical, Inc. | 40 | $782 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $687 |
| Supernus Pharmaceuticals, Inc. | 33 | $613 |
| AbbVie(2 entities) | 27 | $579 |
| Ironshore Pharmaceuticals Inc. | 8 | $190 |
| Axsome Therapeutics, Inc. | 7 | $185 |
| Orexo US, Inc. | 8 | $144 |
| E.r. Squibb & Sons, L.L.C. | 1 | $122 |
| Corium, LLC | 4 | $90 |
| Jazz Pharmaceuticals Inc. | 3 | $51 |
| Shire North American Group Inc | 2 | $40 |
| Boston Scientific | 1 | $39 |
| Alkermes, Inc. | 2 | $32 |
| Arbor Pharmaceuticals, Inc. | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 1 | $30 |
| Indivior Inc. | 1 | $28 |
| Alfasigma USA, Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$1,368
- COBENFY$122
How this compares
$7,274 in reported general payments places this provider in the 95th percentile of 98 child & adolescent psychiatry providers in Maryland.
See all child & adolescent psychiatry providers in Maryland →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 16 | $593 |
| Quetiapine Fumarate | 28 | $443 |
| Guanfacine Hcl ErGuanfacine Hcl | 12 | $307 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $212 |
| Clonazepam | 28 | $133 |
| Trazodone Hcl | 12 | $71 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $64 |
| Sertraline Hcl | 26 | $58 |
| Alprazolam | 17 | $38 |
| Clonidine Hcl | 13 | $32 |
| Metformin Hcl | 12 | $22 |
| Zolpidem Tartrate | 13 | $5 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Frederick
- Anna GonzagaBaltimore$180K
- Michael LabellarteTowson$92K
- Sushma JaniColumbia$11K
- Dejan BudimirovicBaltimore$10K
- Adefolake OshodiRockville$4K
- Jonathan ShepherdWoodlawn$2K
- Suni JaniColumbia$2K
- Mertine JermanyEllicott City$2K
- Charles GordonRockville$1K
- Ibukun Olu IsaacsLeonardtown$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.